APA (7th ed.) Citation

Y, M., C, W., DO, P., Z, C., W, T., RN, C., . . . Y, L. (2026). Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation. Frontiers in immunology, 17, 1821659. https://doi.org/10.3389/fimmu.2026.1821659

Chicago Style (17th ed.) Citation

Y, Men, Wang C, Popoola DO, Cao Z, Tian W, Cooney RN, Meng Q, and Li Y. "Lung-specific Sulfonium Lipid Nanoparticle Formulation of Dexamethasone Suppresses Endotoxin-induced Lung Inflammation." Frontiers in Immunology 17 (2026): 1821659. https://doi.org/10.3389/fimmu.2026.1821659.

MLA (9th ed.) Citation

Y, Men, et al. "Lung-specific Sulfonium Lipid Nanoparticle Formulation of Dexamethasone Suppresses Endotoxin-induced Lung Inflammation." Frontiers in Immunology, vol. 17, 2026, p. 1821659, https://doi.org/10.3389/fimmu.2026.1821659.